Trump said funds unfrozen by the U.S. Treasury and/or sanctions lifted will be deposited into a U.S.-controlled escrow account and used exclusively to buy U.S. food and medical supplies, including corn, wheat and soybeans grown by U.S. farmers.

MOFCOM and eight other ministries issued measures to boost auto aftermarket consumption, calling for stronger insurance support. The notice directs implementation of prior guidance to deepen reform, strengthen supervision and promote high-quality development of new-energy vehicle (NEV) insurance. It requires improving auto insurance protection and service levels, establishing a comprehensive insurance vehicle-model grading system, expanding product supply with ‘basic + variable’ bundled policies, and piloting a vehicle-battery separation insurance model.

Sinovac Biotech’s fully human anti-tetanus monoclonal antibody SNA02-48 injection has entered a Phase III trial, with the first volunteer enrolled at Shenzhen Second People’s Hospital. SNA02-48 was cleared for clinical use in March 2025 and is a recombinant fully human mAb for emergency post-exposure prophylaxis against tetanus. Sinovac is expanding a wound-care portfolio covering active and passive immunity: its adsorbed tetanus vaccine is market-approved; Sinovac-backed Xingmeng Biotech’s Class 1 innovative drug Krebi® (monoclonal antibody injection) is approved for passive immunization of adults exposed to rabies; Sinovac’s lyophilized human rabies vaccine (serum-free Vero cell) is in the regulatory filing stage.